Skip to content

Janux Therapeutics

US · JANX #3187 by market cap Listed 2021
17.92 +1.13 +6.73%
Live - 5344 symbols - heartbeat 549s ago · 2026-10-08 08:14
Pre-market 18.42 +2.79%
After-hours 18.50 +3.24%
Overnight 17.91 -0.06%
Market cap
1.10B
P/B
1.18
EPS
-1.83
Reader sentiment Are you bullish or bearish on JANX?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Evercore Initiates Janux Therapeutics(JANX.US) With Buy Rating, Announces Target Price $23
    Market Newswire · 2026/4/13
  • Rating change
    LifeSci Capital Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $60
    Market Newswire · 2026/5/10
  • Rating change
    Guggenheim Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $68
    Market Newswire · 2026/4/29
  • Rating change
    BofA Securities Maintains Janux Therapeutics(JANX.US) With Buy Rating, Cuts Target Price to $29
    Market Newswire · 2026/2/27
  • Rating change
    A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $24 to $68
    Market Newswire · 2026/4/29
  • Rating change
    Evercore Maintains Janux Therapeutics(JANX.US) With Buy Rating, Cuts Target Price to $22
    Market Newswire · 2026/5/11
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Janux Therapeutics Inc (JANX)
    TipRanks · 2026/6/25
  • H.C. Wainwright Keeps Their Buy Rating on Janux Therapeutics Inc (JANX)
    TipRanks · 2026/10/1
  • Rating change
    JonesTrading Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/4/7
  • Rating change
    Stifel Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $38
    Market Newswire · 2026/4/28
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Janux Therapeutics Inc (JANX) and Progyny (PGNY)
    TipRanks · 2026/5/8
  • Rating change
    A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $14 to $55
    Market Newswire · 2026/8/7
  • H.C. Wainwright Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/10/1
  • Rating change
    A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $14 to $58
    Market Newswire · 2026/5/8
  • William Blair Maintains Janux Therapeutics(JANX.US) With Buy Rating
    Market Newswire · 2026/8/14
  • Wolfe Research Initiates Janux Therapeutics(JANX.US) With Buy Rating, Announces Target Price $23
    Market Newswire · 2026/8/24
  • Rating change
    A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $14 to $60
    Market Newswire · 2026/8/8
  • Truist Financial Initiates Janux Therapeutics(JANX.US) With Buy Rating, Announces Target Price $26
    Market Newswire · 2026/6/25
  • Rating change
    Barclays Downgrades Janux Therapeutics(JANX.US) to Sell Rating, Cuts Target Price to $14
    Market Newswire · 2026/4/20
  • Rating change
    Stifel Maintains Janux Therapeutics(JANX.US) With Buy Rating, Maintains Target Price $35
    Market Newswire · 2026/8/13

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:14:51 · For reference only, not investment advice and not tailored to your situation.